Caxton Advantage Life Sciences Fund

Caxton Advantage Life Sciences Fund

A venture capital and private equity firm investing in companies operating in the life science industry.

Caxton Advantage Life Sciences Fund is a venture capital and private equity firm investing in companies operating in the life science industry that is headquartered in New York City, New York.

Investments

Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera Pharmaceuticals (exit), Regado Biosciences (exit), Gemi X Pharmaceuticals (exit), Corthera (exit), and Mevion Medical Systems.

Timeline

Funded Companies

Company
Industry
Website
Location
Gemin X Pharmaceuticals
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.